SENS · XBRL financial data

Senseonics Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (SENS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	6	8*	5	5	4	8*	6	7	8	14*	12	14
Cost of goods and services sold	5	7*	5	5	8	4*	5	4	5	7*	5	6
Gross profit	1	1*	0	0	(4)	4*	2	3	3	8*	7	9
Research and development	13	11*	10	11	11	9*	7	8	8	9*	9	12
Selling, general and administrative	7	7*	8	9	8	9*	8	10	15	20*	30	33
Operating income (loss)	(19)	(17)*	(18)	(19)	(23)	(14)*	(13)	(14)	(20)	(21)*	(32)	(36)
Interest expense	2	2*	2	2	2	2*	1	1	1	1*	1	2
Other income (expense)	0	0*	0	(0)	(0)	0*	(0)	(0)	0	(0)*	(0)	(0)
Income tax expense (benefit)	0*	0*	0	0	0	0*	0	0	0	0*	0	0
Net income (loss)	(24)	(17)*	(19)	(20)	(24)	(15)*	(14)	(15)	(20)	(21)*	(32)	(37)
Earnings per share, basic‡ USD per share	(0.80)	(0.60)*	(0.60)	(0.60)	(0.80)	(0.40)*	(0.40)	(0.40)	(8.60)	—	(0.71)	(0.63)
Earnings per share, diluted‡ USD per share	(0.80)	(0.60)*	(0.60)	(0.60)	(0.80)	(0.40)*	(0.40)	(0.40)	(8.60)	—	(0.71)	(0.63)
Weighted average shares, basic‡ millions of shares	30	31*	31	31	31	33*	36	41	2	—	46	58
Weighted average shares, diluted‡ millions of shares	30	29*	31	31	31	33*	36	41	2	—	46	58

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2025); filings made before it reported them unadjusted.
† Share count changed about 1/20 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 20x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (SENS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	56	76	91	35	27	75	39	32	34	40	30	45
Short-term investments	70	34	8	50	47	—	25	95	76	54	35	98
Marketable securities	70	34	8	50	47	0	25	95	76	54	35	98
Accounts receivable	—	—	—	—	—	6	5	5	7	12	15	10
Inventory	10	9	8	7	3	4	5	5	6	7	8	8
Prepaid and other current assets	8	7	7	7	6	6	5	5	6	4	5	5
Total current assets	146	130	118	103	88	91	78	142	131	118	92	166
Property and equipment, net	1	1	1	3	3	—	—	—	—	—	—	—
Right-of-use asset	5	5	5	5	5	5	5	5	5	4	6	6
Total assets	154	138	127	112	96	100	87	150	140	126	103	177
Accounts payable	3	5	1	1	2	3	2	2	6	4	3	5
Total current liabilities	17	17	30	33	36	39	11	15	21	24	26	25
Lease liability, non-current	6	6	6	6	6	6	6	6	5	5	6	6
Total liabilities	64	65	70	73	76	79	52	56	62	65	69	87
Accumulated deficit	(852)	(869)	(888)	(908)	(932)	(948)	(962)	(977)	(996)	(1,017)	(1,049)	(1,086)
Total stockholders' equity	52	36	19	1	(17)	(17)	35	95	78	61	34	90
Total liabilities and equity	154	138	127	112	96	100	87	150	140	126	103	177
Common shares outstanding (cover page)‡ millions of shares	26	27	27	27	30	33	33	41	2	42	42	53

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2025); filings made before it reported them unadjusted.
† Share count changed about 1/20 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 20x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (SENS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(24)	(17)*	(19)	(20)	(24)	(15)*	(14)	(15)	(20)	(21)*	(32)	(37)
Stock-based compensation	2*	2*	2	3*	2*	2*	2	3*	3*	3*	2	4*
Depreciation and amortization	0*	1*	0	0*	0*	1*	0	0*	0*	0*	1	1*
Net cash from operating activities	(17)*	(15)*	(20)	(11)*	(15)*	(14)*	(16)	(9)*	(16)*	(18)*	(32)	(30)*
Purchases of property and equipment	—	—	—	—	—	—	0	0*	—	—	0	0*
Net cash from investing activities	28*	36*	25	(44)*	3*	48*	(25)	(70)*	19*	23*	18	(63)*
Proceeds from issuing common stock	—	—	—	—	—	—	26	72*	—	—	3	50*
Net cash from financing activities	17*	(1)*	10	(1)*	4*	14*	6	71*	(0)*	1*	3	109*
Net change in cash	27*	20*	15	(56)*	(8)*	47*	(35)	(8)*	3*	6*	(11)	15*

† Share count changed about 1/20 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 20x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Senseonics Holdings	45	14	(30)*	52.9M	4.7 quarters	Q2 FY26 10-QJun 30, 2026
Pacific Biosciences of California	61	39	(36)*	310.8M	6.7 quarters	Q2 FY26 10-QJun 30, 2026
Cytek Biosciences	74	48	1.4*	130.0M	—	Q2 FY26 10-QJun 30, 2026
Mesa Laboratories	31	60	15	5.6M	—	Q1 FY27 10-QJun 30, 2026
Quantum-Si	24	0.3	(18)*	not reported	6.1 quarters	Q2 FY26 10-QJun 30, 2026
Allient	42	154	14*	17.0M	—	Q2 FY26 10-QJun 30, 2026
Frequency Electronics	61	23	2.6	11.3M	—	Q1 FY27 10-QJul 31, 2026
Quanterix	44	33	(5.1)*	47.3M	18.3 quarters	Q2 FY26 10-QJun 30, 2026
EyePoint	110	0.5	(62)*	86.2M	2.9 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.